Field Medical raises $14m for cardiac ablation technology
Field Medical said it plans to initiate first-in-human studies in early 2024, with results in the middle of the year. Image credit: Shutterstock/Lightspring. Field Medical has closed an oversubscribed seed round totalling $14m, helping advance the company’s catheter ablation platform. The convertible note investment, led by unnamed private investors, will support clinical development of the […]
Wireless brain implant for mental health treatment tested in human
The miniature pacemaker may be able to provide at-home therapy for patients with mental health disorders such as treatment-resistant depression (TRD). Image credit: Motif Neurotech. A company developing an implant that stimulates neural circuits in the brain with the aim of treating mental health disorders has successfully conducted the first-in-human test of its device. Research […]
Signal: Illumina leads $15m investment in Broken String Biosciences
Bioscience giant Illumina has led series A funding into UK-based Broken String. Photo: Tada Images/Shutterstock.com. Geonomics mapping company Broken String Biosciences has achieved a $15m investment in its series A funding round, with Illumina Ventures as the key industry investor. Illumina Ventures is the investment wing of biosciences giant Illumina. Broken String’s core technology is […]
Rare disease drug development needs regulatory incentives to grow in 2024
(From L-R): Kristy Galante, senior director, Immunology Janssen Clinical Excellence and Transformation- Rare diseases, Karin Hoelzer, PhD, director, policy and regulatory affairs, National Organisation for Rare Disorders, Akihiro Ko, CEO, Elixirgen Therapeutics, and Peter Ciszewski, founder and publisher CheckRare. This panel took place at the Clinical Trials in Rare Diseases conference 13-14 September in Princeton, […]
How to connect patients with rare diseases to clinical trials –
Rare disease clinical research is no longer an afterthought for pharmaceutical companies with rapid approvals and increased investment in this space. But conducting trials for conditions that affect relatively few patients still remains challenging compared to conventional ones. The journey that rare disease patients take to find care greatly differs from those who have common […]
European MedTech industry call for change in IVDR and MDR
Conglomerate of medical technologies in Europe send open letter to European commission to address industry concerns on IVDR and MDR. Credit: EQRoy/Shutterstock In an open letter addressed to the European Commissioner for Health and Food Safety, Stella Kyriakides, the medical technology industry has called for change in the current regulation. The open letter addresses the […]
Remote Patient Monitoring market will reach $760m by 2030
Remote Patient Monitoring (RPM) devices are set to grow. Credit: Getty / martin-dm A new report by GlobalData has found that Remote Patient Monitoring (RPM) devices are a growing sector, expected to be worth $760 million by 2030. The report found that the potential of RPM devices to revolutionise at-home care was highlighted during the […]
Q&A – How can AI assist in early detection of kidney disease?
James McCullough, chief executive officer of Renalytix, discusses how AI is addressing early detection of kidney disease. Credit: Marko Aliaksandr/Shutterstock The use of artificial intelligence (AI) to diagnose disease is improving every day and helping clinicians save time and human resources. But the early detection for some diseases is particularly critical in influencing patient treatment […]
PathMaker begins testing non-invasive neuromodulation device in ALS patients
The device which works by suppressing motor neuron hyperexcitability via pads on the skin. Image credit: Shutterstock/Kateryna Kon. PathMaker Neurosystems has started an early feasibility study investigating its non-invasive neuromodulation device in patients with amyotrophic lateral sclerosis (ALS). The first-in-human trial will evaluate the company’s MyoRegulator device which works by suppressing motor neuron hyperexcitability via […]
FDA clears Attune Medical device for prevention of ablation-related oesophageal injury
Though rare, the oesophagus can be injured during cardiac ablation procedures, leading to potentially life-threatening complications. Image credit: Shutterstock/SciePro. The US Food and Drug Administration has granted Attune Medical’s Esophageal Heat Transfer Device (ensoETM) De Novo marketing authorisation, opening the device’s route to operating rooms in the US. The system reduces the likelihood of ablation-related […]